Author

Arvind Bangaru

Georgia Institute of Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

Adegboyega K. OyelereiD· 1 shared Alexis JohnstoniD· 1 shared Bocheng WuiD· 1 shared Brandon J. Clarke· 1 shared Dipak T. WalunjiD· 1 shared Janani Murugan· 1 shared Jeremiah Olorunjuwon OlugbamiiD· 1 shared Nathaniel A. HathawayiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adegboyega K. OyelereORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Transcriptomic Signature and PROTAC Strategy Revealed Histone Lysine Demethylase as a Target of Anticancer Activity of Deferiprone.

Alexis Johnston, Jeremiah Olorunjuwon Olugbami, Dipak T. Walunj, Arvind Bangaru, Bocheng Wu, Ryan Kern, Ruiqiao Yang, Travis J. Nelson, Brandon J. Clarke, Janani Murugan, Nathaniel A. Hathaway, Yuhong Fan, Adegboyega K. Oyelere

This study identifies KDM inhibition as a key anticancer mechanism of DFP and demonstrates PROTACs as a strategy to enhance its therapeutic potential.

ACS Omega · Apr 28, 2026Peer-reviewedCancer Biology